Cargene

Edit info

Founded: 2020

Location: Singapore , Singapore

Employee range: 11 - 50

Clinical stage: RD

Therapy area: Liver diseases

Drug types: HEP,OPH, CVV

Lead product: Undisclosed

Funding: $19.2M A Dec 2021

cargene.com

linkedin.com

Drug notes:

Undisclosed programs RD eye diseases, cardiometabolic diseases

About:

Lerna Biopharma (Cargene), founded in 2020, develops oligonucleotide therapeutics for liver disease using their proprietary nucleic acid and delivery platforms. They are using RNA technology to leverage the liver’s intrinsic regenerative potential. Lerna Bio utilizes their Lerna-GalNAc delivery platform to target liver hepatocytes and their extra-hepatic delivery platform to target the anterior and posterior eye. They currently have operations in Singapore, China, and the US.

Jobs:

Main

Contact: recruit@workinbiotech.com